Similar Posts
Blog Post: Day 39 of $QQQ short term up-trend; Much weakness on Friday: more new lows than highs and only 8 at ATH, lowest since April 24! Another possible head and shoulder’s top forming, see daily chart. GMI=4 but Green, see table.
Last August I wrote that I saw a possible head and shoulders top pattern forming, but the market broke above the right shoulder and moved higher instead. I have drawn in another possible head and shoulders pattern in QQQ that has been forming. This week we will see if it is resolved like the earlier…
Blog Post: Day 36 of $QQQ short term down-trend; Major indexes reman in daily BWR down-trends, see as an example, daily Guppy chart of $QQQ
Blog Post: Day 36 of $QQQ short term down-trend; Major indexes reman in daily BWR down-trends, see as an example, daily Guppy chart of $QQQ | Wishing Wealth Blog Skip to content Screenshot Related Categories All Posts Source link
A Strong TFSA Stock Offering a 6% Yield and Monthly Paycheques
A lot of people think running a small business is a great way to earn passive income. And it can be, but only if you make it past the first few years. The reality is that most small businesses fail. Even the ones that survive often end up being anything but passive. Owners are working…
FIIs’ November surprise: A tale of two halves in Indian stocks – Sell-Off to Buy-In
Foreign Institutional Investors (FIIs) displayed a dramatic shift in behaviour during November, creating a “tale of two halves.” The first half of the month saw FIIs as net sellers, selling Indian stocks worth Rs 22,420 crore across most sectors. However, the second half marked a reversal, with FIIs turning net buyers to the tune of…
Monthly Cash Flow: Discover This 9% Dividend Payer
Consistent, stable cash flow is the characteristic that dividend stocks must have to win income-focused investors over. Stable cash flows also serve as incentives to maintain investors’ loyalty for years, if not forever. Some may even offer substantial capital gain through price appreciation. However, if you want a pure but strong dividend power play, discover…
Zydus Lifesciences Gets USFDA Nod for MS Drug; Oncology Plant Cleared, Shares Flat
November 14, 2025November 14, 2025 Shares of Zydus Lifesciences Ltd are trading flat after hitting a day’s high of Rs 952.95 on 14th November, even as the company announced it has received final approval from the USFDA for Diroximel Fumarate delayed-release capsules (231 mg), used to treat relapsing forms…
